multiplex diagnostics
A handful of firms have announced they are developing at-home combo kits that can detect and differentiate COVID-19, flu A, and B on current testing platforms.
Luminex Obtains CE Marking for MDx Panel to Detect Flu A/B, RSV, COVID-19
Results are generated in a single workflow from a patient sample, which enables rapid detection for the differential diagnosis of a single pathogen.
The firm expects to establish a US-based development and manufacturing footprint for its multiplex PCR assay kits.
The firm submitted a low-cost RT-LAMP device and COVID test to the FDA for Emergency Use Authorization this week.
Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M
Psyros said its single-molecule counting technology would enable multiplexing and the measurement of biomarkers at femtomolar concentrations in 10 minutes or less.